Designed for those who require a more comprehensive approach to hunger and glucose regulation
Zhang Y, Liu Q, Gao Y, Liu B, Liu H, Cao M, et al
Peptide-Enabled Targeted Delivery Systems for Therapeutic Applications
When to Consider Testing Testing may be useful: Before starting a GLP-1 medicine After a meaningful treatment change When diabetes goals are not being met When persistent gastrointestinal symptoms develop When food or fluid intake has significantly decreased When kidney or liver risk is already present When a prior result was abnormal When a healthcare provider recommends follow-up Testing frequency should be based on individual risk rather than an automatic monthly or quarterly panel for everyone
Looking at weight, mood, and hormones together, rather than in separate silos, is the whole premise of how we practice
Shibata et al